Expiring federal contract · order under a contract vehicle
75H71226F28026 — Cepheid
Department of Health and Human Services · Indian Health Service
- Contract / PIID
- 75H71226F28026
- Incumbent
- Cepheid
- Incumbent UEI
- W6HQTMWB9Q28
- Current end date
- February 7, 2027
- Potential total value
- $272,000
- Obligated
- $272,000
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6515 — MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Set-aside
- Full & Open
- Start date
- March 5, 2026
- Place of performance
- AZ
- Award type
- BPA CALL
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
CEPHEID LAB REAGANT TEST KITS
Likely rebid window (estimate)
- Sources Sought / RFI: about Feb 2026 – Aug 2026 (6–12 months before the end date)
- RFP: about Oct 2026 – Dec 2026 (2–4 months before the end date)
Now inside the estimated RFP window.
This is an order under contract vehicle 75H71223A00001. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325413)
- 75H71025P00975 — Becton, Dickinson And Company · ends November 30, 2026 · $103K
- 75H71226F28022 — Cepheid · ends January 11, 2027 · $460K
- 75N90026P00079 — Werfen USA LLC · ends January 31, 2027 · $170K
- 75H71226F28010 — Biomerieux INC · ends February 26, 2027 · $240K
- 75H70722P00094 — Cepheid · ends February 28, 2027 · $2.8M
- 75H70723F80016 — Abbott Laboratories INC. · ends February 28, 2027 · $310K
- 75H71025F80116 — Roche Diabetes Care INC · ends March 31, 2027 · $244K
- 75H71226F28027 — Cepheid · ends April 14, 2027 · $600K
- 75H70726F80013 — Fisher Scientific Company L.L.C. · ends April 30, 2027 · $610K
- 75A50123C00036 — Siro Diagnostics, INC. · ends May 1, 2027 · $28M